Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Yin, Ming ^a   Liao, Zhongxing ^a   Huang, Yu Jing ^a   Liu, Zhensheng ^a   Yuan, Xianglin ^b   Gomez, Daniel ^a   Wang, Li E ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; XRCC2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHEMORADIOTHERAPY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HOMOLOGOUS RECOMBINATION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NBN GENE; OVERALL SURVIVAL; PROGNOSIS; RAD51 GENE; RADIATION PNEUMONIA; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; XRCC2 GENE; XRCC3 GENE; GENETIC RECOMBINATION; GENETICS; LUNG TUMOR; MIDDLE AGED; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; DNA-BINDING PROTEINS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION PNEUMONITIS; RECOMBINATION, GENETIC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79957529818     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020055     Document Type: Article

References (40)

1. Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, et al. (2005) Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 128: 452-462.
2. Cullen MH, Billingham LJ, Woodroffe CM, Chetiyawardana AD, Gower NH, et al. (1999) Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 17: 3188-3194.
3. Nikjoo H, O'Neill P, Wilson WE, Goodhead DT, (2001) Computational approach for determining the spectrum of DNA damage induced by ionizing radiation. Radiat Res 156: 577-583.
4. Ward JF, (1990) The yield of DNA double-strand breaks produced intracellularly by ionizing radiation: a review. Int J Radiat Biol 57: 1141-1150.
5. Jackson SP, (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis 23: 687-696.
6. Qiao GB, Wu YL, Yang XN, Zhong WZ, Xie D, et al. (2005) High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients. Br J Cancer 93: 137-143.
7. Ohnishi K, Scuric Z, Schiestl RH, Okamoto N, Takahashi A, et al. (2006) siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status. Radiat Res 166: 454-462.
8. Yanagisawa T, Urade M, Yamamoto Y, Furuyama J, (1998) Increased expression of human DNA repair genes, XRCC1, XRCC3 and RAD51, in radioresistant human KB carcinoma cell line N10. Oral Oncol 34: 524-528.
9. Tambini CE, Spink KG, Ross CJ, Hill MA, Thacker J, (2010) The importance of XRCC2 in RAD51-related DNA damage repair. DNA Repair (Amst) 9: 517-525.
10. Tauchi H, Matsuura S, Kobayashi J, Sakamoto S, Komatsu K, (2002) Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 21: 8967-8980.
11. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, et al. (2006) Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66: 1399-1407.
12. Cancer Therapy Evaluation Program (2003) Common terminology criteria for adverse events, version 3. Available: http://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_glossary.pdf. Accessed 2011 April 25.
13. Armstrong J, Raben A, Zelefsky M, Burt M, Leibel S, et al. (1997) Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 44: 17-22.
14. Hernando ML, Marks LB, Bentel GC, Zhou SM, Hollis D, et al. (2001) Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51: 650-659.
15. Fu XL, Huang H, Bentel G, Clough R, Jirtle RL, et al. (2001) Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 50: 899-908.
16. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, et al. (1999) Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45: 323-329.
17. Kwa SL, Lebesque JV, Theuws JC, Marks LB, Munley MT, et al. (1998) Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42: 1-9.
18. Maeda T, Ueoka H, Tabata M, Kiura K, Shibayama T, et al. (2000) Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis. Jpn J Clin Oncol 30: 534-541.
19. Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, et al. (2009) Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27: 3370-3378.
20. Williams GJ, Lees-Miller SP, Tainer JA, (2010) Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks. DNA Repair (Amst) 9: 1299-1306.
21. Chistiakov DA, Voronova NV, Chistiakov PA, (2008) Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol 47: 809-824.
22. Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, et al. (2008) XRCC1 Arg399Gln and RAD51 5′UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients. Breast Cancer Res Treat 109: 183-185.
23. Li D, Liu H, Jiao L, Chang DZ, Beinart G, et al. (2006) Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res 66: 3323-3330.
24. Liu L, Yang L, Zhang Y, Xu ZF, Yu MH, et al. (2008) Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia. Zhonghua Yi Xue Za Zhi 88: 378-382.
25. Damaraju S, Murray D, Dufour J, Carandang D, Myrehaug S, et al. (2006) Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res 12: 2545-2554.
26. Popanda O, Tan XL, Ambrosone CB, Kropp S, Helmbold I, et al. (2006) Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev 15: 1048-1050.
27. Aka P, Mateuca R, Buchet JP, Thierens H, Kirsch-Volders M, (2004) Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations? Mutat Res 556: 169-181.
28. Araujo FD, Pierce AJ, Stark JM, Jasin M, (2002) Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks. Oncogene 21: 4176-4180.
29. Kobayashi J, Antoccia A, Tauchi H, Matsuura S, Komatsu K, (2004) NBS1 and its functional role in the DNA damage response. DNA Repair (Amst) 3: 855-861.
30. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, et al. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14: 927-939.
31. Hasselbach L, Haase S, Fischer D, Kolberg HC, Sturzbecher HW, (2005) Characterisation of the promoter region of the human DNA-repair gene Rad51. Eur J Gynaecol Oncol 26: 589-598.
32. Du LQ, Wang Y, Wang H, Cao J, Liu Q, et al. (2010) Knockdown of Rad51 expression induces radiation- and chemo-sensitivity in osteosarcoma cells. Med Oncol [Epub ahead of print].
33. Brown ET, Holt JT, (2009) Rad51 overexpression rescues radiation resistance in BRCA2-defective cancer cells. Mol Carcinog 48: 105-109.
34. Inoue A, Kunitoh H, Sekine I, Sumi M, Tokuuye K, et al. (2001) Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 49: 649-655.
35. Yamano M, Ogino H, Shibamoto Y, Horii N, (2007) Relationship between radiation pneumonitis and prognosis in patients with primary lung cancer treated by radiotherapy. Kurume Med J 54: 57-63.
36. Movsas B, Raffin TA, Epstein AH, Link CJ Jr, (1997) Pulmonary radiation injury. Chest 111: 1061-1076.
37. Rodemann HP, Dittmann K, Toulany M, (2007) Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol 83: 781-791.
38. Meirovitz A, Kuten M, Billan S, Abdah-Bortnyak R, Sharon A, et al. (2010) Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer-a prospective pilot study. Radiat Oncol 5: 16.
39. Legue F, Guitton N, Brouazin-Jousseaume V, Colleu-Durel S, Nourgalieva K, et al. (2001) IL-6 a key cytokine in in vitro and in vivo response of Sertoli cells to external gamma irradiation. Cytokine 16: 232-238.
40. Xia DH, Xi L, Xv C, Mao WD, Shen WS, et al. (2010) The protective effects of ambroxol on radiation lung injury and influence on production of transforming growth factor beta1 and tumor necrosis factor alpha. Med Oncol 27: 697-701.